发明名称 |
D-serine transporter inhibitors as pharmaceutical compositions for the treatment of central nervous system disorders |
摘要 |
The present invention relates to pharmaceutical compositions comprising D-serine transporter inhibitors and therapeutic methods using such pharmaceutical compositions in methods for the treatment of central nervous system disorders. |
申请公布号 |
US8741955(B2) |
申请公布日期 |
2014.06.03 |
申请号 |
US201213480221 |
申请日期 |
2012.05.24 |
申请人 |
Allergan, Inc. |
发明人 |
Foster Alan C.;Li Yong-Xin;Staubli Ursula;Viswanath Veena;Luhrs Lauren |
分类号 |
A01N37/12;A01N37/44;A61K31/195 |
主分类号 |
A01N37/12 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for the alleviation of a central nervous system disorder which is schizophrenia caused by a deficit in N-methyl-D-aspartate receptor function, the method comprising administering to a subject in need thereof an acceptable pharmaceutical composition containing a therapeutically effective amount of at least one ASCT1 inhibitor compound, which is L-4-fluoro phenylglycine and at least one ASCT2 inhibitor compound, which is L-4-fluoro phenylglycine.
|
地址 |
Irvine CA US |